Drawing for ATOPIDINE

USPTO serial 88615524

ATOPIDINE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
NUNLEY, CHRISTOPHER MICHAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ATOPIDINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Moisturizing creams; Non-medicated skin care creams and lotions; Non-medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Skin creams in liquid and in solid form; Skin creams in liquid and solid form; Skin and body topical lotions, creams and oils for cosmetic use; Sunscreen creamsACTIVE—
005Anti-inflammatory ointments; Anti-itch ointment; Antibiotic ointments; Gels, creams and solutions for dermatological use; Herbal anti-itch and sore skin ointment for pets; Homeopathic anti-inflammatory ointment; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated ointments for treating dermatological conditions; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated sunburn ointments; Non-medicated, therapeutic skin creams for the treatment of atopic dermatitis and radiation dermatitis; Sunburn ointments; Topical gel for medical and therapeutic treatment of atopic dermatitis and radiation dermatitis; Topical first aid gelACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Apr 18, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 18, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 29, 2021EX3GSOU EXTENSION 3 GRANTED—
Oct 19, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Oct 18, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 18, 2021PETGPETITION TO REVIVE-GRANTED—
Oct 18, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Oct 18, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 18, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 17, 2021EXT3SOU EXTENSION 3 FILED—
May 19, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2021EX2GSOU EXTENSION 2 GRANTED—
May 18, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 20, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Apr 19, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Apr 19, 2021PETGPETITION TO REVIVE-GRANTED—
Apr 19, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Apr 19, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 19, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 17, 2021EXT2SOU EXTENSION 2 FILED—
Sep 4, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 2, 2020EX1GSOU EXTENSION 1 GRANTED—
Sep 2, 2020EXT1SOU EXTENSION 1 FILED—
Sep 2, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 17, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 21, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 21, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 1, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 16, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 15, 2019DOCKASSIGNED TO EXAMINER—
Sep 21, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance